About the Authors
- Janna Sand-Dejmek
-
* E-mail: jannasd@gmail.com
Affiliations Experimental Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden, Surgery, Department of Clinical Sciences Malmö, Lund University, Skåne University Hospital, Malmö, Sweden
- Roy Ehrnström
-
Affiliation Clinical Pathology, Department of Laboratory Medicine Malmö, Lund University, Skåne University Hospital, Malmö, Sweden
- Pontus Berglund
-
Affiliation Experimental Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden
- Tommy Andersson
-
Affiliation Experimental Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden
- Lisa Ryden
-
Affiliation Surgery, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden
Competing Interests
JSD and TA are shareholders of WntResearch AB. TA is part-time CSO of WntResearch AB. WntResearch AB owns two patents on the use of Foxy-5 peptide as an anti-metastatic compound. WntResearch AB is about to initiate a phase I study with the Foxy-5 peptide. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JSD TA LR. Performed the experiments: JSD RE PB. Analyzed the data: JSD RE LR TA PB. Contributed reagents/materials/analysis tools: TA LR. Wrote the paper: JSD TA LR.